From October 1, 2022 to December 31, 2022, the company has repurchased 411,761 shares, representing 1.22% for $7.64 million. With this, the company has completed the repurchase of 3,235,823 shares, representing 9.34% for $61.88 million under the buyback announced on August 16, 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.02 USD | +0.76% |
|
+1.04% | +3.93% |
01/07 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Growth-Defensive Index | CI |
01/07 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Defensive Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.93% | 1.04B | |
+61.77% | 856B | |
+38.95% | 631B | |
-3.93% | 359B | |
+15.32% | 325B | |
+9.01% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.87% | 177B | |
+2.17% | 165B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Tranche Update on Collegium Pharmaceutical, Inc.'s Equity Buyback Plan announced on August 16, 2021.